Genmab A/S (GMAB) Shareholder Equity
- 2025-12-31: Retained EarningsDKK (m); Retained EarningsUSD $4.10B.
- 2025-06-30: Retained EarningsDKK (m); Retained EarningsUSD $3.60B.
- 2024-12-31: Retained EarningsDKK 23.55B; Retained EarningsUSD $3.39B.
- 2024-06-30: Retained EarningsDKK 18.13B; Retained EarningsUSD (m).
Genmab A/S Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Retained Earnings DKK | Retained Earnings USD |
|---|---|---|
| 2025-12-31 | (m) | $4.10B |
| 2025-06-30 | (m) | $3.60B |
| 2024-12-31 | 23.55B | $3.39B |
| 2024-06-30 | 18.13B | (m) |
| 2023-12-31 | 19.02B | $2.74B |
| 2023-06-30 | 16.16B | (m) |
| 2022-12-31 | 14.81B | (m) |
| 2022-06-30 | 12.24B | (m) |
| 2021-12-31 | 9.93B | (m) |
| 2021-06-30 | 8.16B | (m) |
| 2020-12-31 | 7.11B | (m) |
| 2020-06-30 | 5.88B | (m) |
| 2019-12-31 | 2.13B | (m) |
| 2019-06-30 | 32.02M | (m) |
| 2018-12-31 | -198.00M | (m) |